Dyes & Pigments · Founded 1993 · www.shreepushkar.com · BSE 539334 · NSE SHREEPUSHK · ISIN INE712K01011
No Notes Added Yet
Business
Shree Pushkar Chemicals & Fertilisers Ltd. (SHREEPUSHK) is an Indian manufacturing company primarily engaged in the production and sale of chemicals and fertilisers. Its core business involves the manufacturing of dye intermediates, dyes, and various fertiliser products. The company operates an integrated manufacturing facility, producing a range of sulphuric acid-based chemicals which serve as key inputs for its dye intermediates and fertiliser segments. It makes money by selling these manufactured products to various industrial customers (e.g., textile, paper, leather industries for dyes/intermediates) and to agricultural customers (for fertilisers).
Revenue Mix
The company broadly operates in two main segments:
Chemicals: This segment includes the manufacturing of dye intermediates (e.g., H-acid, K-acid, Gamma acid, etc.), specialty chemicals, and dyestuffs. These products cater to the textile, paper, leather, and other chemical-intensive industries.
Fertilisers: This segment focuses on producing and selling various grades of fertilisers, including Single Super Phosphate (SSP) and other micro-nutrient fertilisers, primarily catering to the agricultural sector.
The company also has an ancillary business of trading and processing of agricultural products like cattle feed. While specific revenue contributions are not provided in the prompt, the company name suggests a significant presence in both chemicals (specifically dyes) and fertilisers.
Industry
SHREEPUSHK operates in the diverse Indian chemical and fertiliser industries. The Dyes & Pigments industry is fragmented with numerous players, ranging from large integrated corporations to smaller specialty manufacturers. The fertiliser industry, particularly SSP, also features many regional players. SHREEPUSHK positions itself as an integrated manufacturer, benefiting from backward integration into key raw materials like sulphuric acid, which enhances cost efficiency and reduces dependency on external suppliers. This integration allows it to compete on cost and product quality within its chosen niches against both domestic and international players.
MOAT
Backward Integration: The company's significant backward integration into sulphuric acid and other key chemical inputs provides a cost advantage and stability in raw material sourcing, reducing vulnerability to price volatility and supply chain disruptions.
Diversified Product Portfolio: The presence in both chemicals (dye intermediates, dyes) and fertilisers, along with specialty chemicals, helps de-risk the business by reducing reliance on a single end-market.
Operational Efficiency: Integrated manufacturing processes and focus on resource optimization (e.g., captive power generation from waste heat) contribute to operational efficiency and cost competitiveness.
Growth Drivers
Increasing Demand from End-User Industries: Growth in the textile, paper, and leather industries (both domestic and export) will drive demand for dyes and intermediates.
Agricultural Sector Growth: Government focus on agricultural productivity, favorable monsoons, and increasing awareness of soil health can boost fertiliser demand.
Capacity Expansion: Any ongoing or planned capacity expansions in existing or new product lines would directly contribute to revenue growth.
Product Diversification: Expansion into higher-margin specialty chemicals or new fertiliser grades could unlock additional growth avenues.
Export Opportunities: Leveraging its cost-competitive manufacturing, the company can expand its export footprint for chemicals and dyes.
Risks
Raw Material Price Volatility: Fluctuations in prices of key raw materials such as sulphur, rock phosphate, and other crude oil derivatives can impact profitability.
Regulatory Changes: Environmental regulations regarding chemical manufacturing, and government policies/subsidies related to fertilisers, can significantly affect operations and profitability.
Intense Competition: The Dyes & Pigments and Fertiliser industries are competitive, which can put pressure on pricing and margins.
Economic Slowdown: A slowdown in the domestic or global economy could reduce demand from end-user industries (textiles, agriculture), affecting sales.
Monsoon Dependency: Fertiliser sales are highly dependent on the monsoon season in India, making the agricultural segment susceptible to weather risks.
Management & Ownership
Shree Pushkar Chemicals & Fertilisers Ltd. is a promoter-led company, characteristic of many Indian businesses. The management team likely possesses considerable experience within the chemical and fertiliser sectors. Promoter holding typically reflects a long-term strategic vision and commitment to the business. The ownership structure generally includes a significant promoter stake, along with institutional and public shareholding.
Outlook
Shree Pushkar Chemicals & Fertilisers Ltd. benefits from its integrated manufacturing model and diversified presence across the chemicals and fertiliser value chains. The underlying demand drivers from the textile, paper, and agricultural sectors provide a stable foundation. The company's backward integration strategy offers a degree of resilience against raw material price shocks and supply chain issues. However, it operates in cyclical and commodity-driven industries susceptible to raw material price volatility, stringent environmental regulations, and intense competition. While capacity expansions and product diversification could drive future growth, profitability remains sensitive to global commodity cycles and domestic agricultural conditions. The outlook is balanced, recognizing both the inherent operational strengths and the external market and regulatory challenges.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 191 | 194 | 176 | 217 | 219 | 255 | 255 | 249 | 218 | 280 |
| Other Income | 3 | 3 | 3 | 2 | 2 | 4 | 3 | 5 | 2 | 5 |
| Total Income | 193 | 198 | 178 | 219 | 222 | 258 | 258 | 253 | 220 | 285 |
| Total Expenditure | 172 | 177 | 157 | 195 | 195 | 225 | 229 | 227 | 196 | 248 |
| Operating Profit | 21 | 21 | 22 | 24 | 27 | 33 | 30 | 27 | 24 | 37 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 3 |
| Depreciation | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 16 | 15 | 16 | 18 | 20 | 26 | 22 | 20 | 17 | 28 |
| Provision for Tax | 3 | 2 | 3 | 2 | 4 | 5 | 4 | 2 | 5 | 5 |
| Profit After Tax | 13 | 13 | 13 | 16 | 17 | 21 | 18 | 18 | 13 | 23 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | 0 | -0 |
| Profit After Adjustments | 13 | 13 | 13 | 16 | 17 | 21 | 18 | 18 | 13 | 23 |
| Adjusted Earnings Per Share | 4.1 | 4.1 | 4.1 | 4.9 | 5.1 | 6.5 | 5.6 | 5.6 | 4 | 7.1 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 306 | 395 | 452 | 346 | 355 | 584 | 684 | 726 | 806 | 977 | 1002 |
| Other Income | 2 | 2 | 3 | 4 | 7 | 7 | 8 | 11 | 11 | 14 | 15 |
| Total Income | 308 | 397 | 455 | 351 | 362 | 591 | 692 | 737 | 817 | 990 | 1016 |
| Total Expenditure | 254 | 334 | 385 | 297 | 312 | 505 | 616 | 666 | 722 | 877 | 900 |
| Operating Profit | 54 | 63 | 70 | 54 | 50 | 87 | 76 | 71 | 95 | 113 | 118 |
| Interest | 3 | 3 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 4 | 7 |
| Depreciation | 5 | 8 | 10 | 11 | 13 | 14 | 19 | 22 | 23 | 23 | 24 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 46 | 52 | 56 | 40 | 36 | 71 | 56 | 48 | 70 | 85 | 87 |
| Provision for Tax | 16 | 16 | 15 | 4 | 7 | 15 | 18 | 11 | 11 | 15 | 16 |
| Profit After Tax | 30 | 37 | 41 | 36 | 29 | 56 | 37 | 37 | 59 | 70 | 72 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 30 | 37 | 41 | 36 | 29 | 56 | 37 | 37 | 59 | 70 | 72 |
| Adjusted Earnings Per Share | 10 | 12.1 | 13.3 | 11.6 | 9.3 | 18 | 11.8 | 11.7 | 18.1 | 21.7 | 22.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 21% | 13% | 22% | 0% |
| Operating Profit CAGR | 19% | 14% | 18% | 0% |
| PAT CAGR | 19% | 24% | 19% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 22% | 37% | 18% | 11% |
| ROE Average | 12% | 11% | 11% | 13% |
| ROCE Average | 13% | 11% | 12% | 15% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 193 | 237 | 284 | 306 | 339 | 396 | 438 | 474 | 539 | 610 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 3 | 7 | 4 | 8 | 8 | 2 | 0 | 0 | 23 |
| Other Non-Current Liabilities | 11 | 14 | 21 | 19 | 23 | 30 | 36 | 40 | 45 | 49 |
| Total Current Liabilities | 55 | 137 | 114 | 114 | 119 | 204 | 188 | 201 | 293 | 298 |
| Total Liabilities | 260 | 391 | 426 | 444 | 489 | 637 | 664 | 715 | 877 | 981 |
| Fixed Assets | 123 | 166 | 172 | 164 | 175 | 195 | 313 | 295 | 308 | 305 |
| Other Non-Current Assets | 14 | 14 | 24 | 119 | 154 | 132 | 12 | 62 | 86 | 182 |
| Total Current Assets | 123 | 211 | 230 | 161 | 161 | 310 | 339 | 357 | 483 | 493 |
| Total Assets | 260 | 391 | 426 | 444 | 489 | 637 | 664 | 715 | 877 | 981 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 1 | 3 | 13 | 4 | 0 | 3 |
| Cash Flow from Operating Activities | 17 | -5 | 56 | 76 | 41 | 42 | 50 | 16 | 38 | 102 |
| Cash Flow from Investing Activities | -12 | -50 | -40 | -61 | -33 | -63 | -38 | -58 | -35 | -128 |
| Cash Flow from Financing Activities | -5 | 55 | -15 | -14 | -7 | 31 | -22 | 38 | -0 | 25 |
| Net Cash Inflow / Outflow | 0 | -0 | 0 | 0 | 2 | 10 | -9 | -3 | 2 | -2 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 1 | 3 | 13 | 4 | 0 | 3 | 1 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 10 | 12.09 | 13.29 | 11.58 | 9.25 | 18.01 | 11.77 | 11.72 | 18.13 | 21.68 |
| CEPS(Rs) | 11.82 | 14.67 | 16.54 | 15.3 | 13.36 | 22.6 | 17.63 | 18.55 | 25.13 | 28.94 |
| DPS(Rs) | 1.5 | 0 | 1.5 | 0.5 | 1 | 2 | 1.5 | 1.5 | 2 | 2.1 |
| Book NAV/Share(Rs) | 63.86 | 74.15 | 89.71 | 99.3 | 109.93 | 127.05 | 138.37 | 148.56 | 166.64 | 186.35 |
| Core EBITDA Margin(%) | 16.95 | 15.45 | 14.79 | 14.24 | 12.18 | 13.61 | 10 | 8.34 | 10.41 | 10.19 |
| EBIT Margin(%) | 15.87 | 13.93 | 13.18 | 12.16 | 10.51 | 12.45 | 8.45 | 6.86 | 8.93 | 9.17 |
| Pre Tax Margin(%) | 15.04 | 13.21 | 12.36 | 11.55 | 10.1 | 12.12 | 8.13 | 6.64 | 8.65 | 8.71 |
| PAT Margin (%) | 9.88 | 9.25 | 9.04 | 10.31 | 8.04 | 9.51 | 5.44 | 5.1 | 7.27 | 7.18 |
| Cash Profit Margin (%) | 11.67 | 11.22 | 11.24 | 13.62 | 11.6 | 11.93 | 8.15 | 8.08 | 10.08 | 9.58 |
| ROA(%) | 11.63 | 11.23 | 10 | 8.21 | 6.12 | 9.86 | 5.72 | 5.38 | 7.37 | 7.55 |
| ROE(%) | 15.66 | 17.53 | 16.35 | 12.28 | 8.85 | 15.2 | 8.98 | 8.17 | 11.62 | 12.28 |
| ROCE(%) | 23.33 | 21.59 | 18.8 | 12.23 | 9.9 | 16.47 | 11.65 | 9.16 | 11.81 | 13.03 |
| Receivable days | 72.8 | 67.86 | 74.41 | 92.21 | 78.99 | 53.61 | 59.38 | 72.05 | 75.37 | 66.06 |
| Inventory Days | 37.97 | 52.69 | 58.39 | 65.54 | 60.37 | 45.94 | 46.52 | 36.59 | 50.51 | 55.41 |
| Payable days | 38.62 | 49.07 | 57.5 | 83.55 | 88.59 | 68.85 | 76.7 | 64.37 | 82.8 | 89.81 |
| PER(x) | 20.04 | 16.77 | 12.38 | 6.38 | 14.77 | 15.52 | 12.56 | 13.59 | 14.7 | 13.91 |
| Price/Book(x) | 3.14 | 2.74 | 1.83 | 0.74 | 1.24 | 2.2 | 1.07 | 1.07 | 1.6 | 1.62 |
| Dividend Yield(%) | 0.75 | 0 | 0.91 | 0.68 | 0.73 | 0.72 | 1.01 | 0.94 | 0.75 | 0.7 |
| EV/Net Sales(x) | 1.96 | 1.67 | 1.13 | 0.8 | 1.34 | 1.61 | 0.78 | 0.84 | 1.16 | 1.13 |
| EV/Core EBITDA(x) | 11.07 | 10.48 | 7.38 | 5.19 | 9.52 | 10.82 | 6.95 | 8.56 | 9.89 | 9.74 |
| Net Sales Growth(%) | 0 | 29.22 | 14.33 | -23.36 | 2.48 | 64.54 | 17.13 | 6.16 | 11.03 | 21.13 |
| EBIT Growth(%) | 0 | 13.49 | 8.12 | -29.27 | -11.43 | 94.93 | -20.52 | -13.83 | 44.61 | 24.4 |
| PAT Growth(%) | 0 | 20.95 | 11.76 | -12.57 | -20.09 | 94.65 | -32.97 | -0.46 | 58.16 | 19.59 |
| EPS Growth(%) | 0 | 20.95 | 9.92 | -12.89 | -20.09 | 94.65 | -34.64 | -0.46 | 54.68 | 19.59 |
| Debt/Equity(x) | 0.08 | 0.29 | 0.17 | 0.17 | 0.17 | 0.23 | 0.16 | 0.23 | 0.18 | 0.21 |
| Current Ratio(x) | 2.22 | 1.54 | 2.03 | 1.41 | 1.35 | 1.52 | 1.8 | 1.78 | 1.65 | 1.65 |
| Quick Ratio(x) | 1.65 | 0.94 | 1.48 | 0.87 | 0.89 | 1.07 | 1.36 | 1.47 | 1.1 | 1.2 |
| Interest Cover(x) | 19.13 | 19.26 | 16.03 | 19.78 | 25.7 | 37.1 | 26.11 | 31.88 | 31.48 | 19.92 |
| Total Debt/Mcap(x) | 0.02 | 0.11 | 0.09 | 0.23 | 0.14 | 0.11 | 0.15 | 0.21 | 0.12 | 0.13 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.6 | 68.6 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 |
| FII | 1.39 | 1.59 | 1.62 | 0.41 | 0.86 | 0.42 | 1.47 | 0.59 | 0.43 | 0.51 |
| DII | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.38 | 0.29 | 0 |
| Public | 30.01 | 29.8 | 29.02 | 30.23 | 29.78 | 30.22 | 29.17 | 29.67 | 29.92 | 30.13 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.17 | 2.17 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 |
| FII | 0.04 | 0.05 | 0.05 | 0.01 | 0.03 | 0.01 | 0.05 | 0.02 | 0.01 | 0.02 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0 |
| Public | 0.95 | 0.94 | 0.94 | 0.98 | 0.96 | 0.98 | 0.94 | 0.96 | 0.97 | 0.97 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.16 | 3.16 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +21% | +13% | +22% | — |
| Operating Profit CAGR | +19% | +14% | +18% | — |
| PAT CAGR | +19% | +24% | +19% | — |
| Share Price CAGR | +22% | +37% | +18% | +11% |
| ROE Average | +12% | +11% | +11% | +13% |
| ROCE Average | +13% | +11% | +12% | +15% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.6 | 68.6 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 |
| FII | 1.39 | 1.59 | 1.62 | 0.41 | 0.86 | 0.42 | 1.47 | 0.59 | 0.43 | 0.51 |
| DII | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.38 | 0.29 | 0 |
| Public | 30.01 | 29.8 | 29.02 | 30.23 | 29.78 | 30.22 | 29.17 | 29.67 | 29.92 | 30.13 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.17 | 2.17 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 |
| FII | 0.04 | 0.05 | 0.05 | 0.01 | 0.03 | 0.01 | 0.05 | 0.02 | 0.01 | 0.02 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0 |
| Public | 0.95 | 0.94 | 0.94 | 0.98 | 0.96 | 0.98 | 0.94 | 0.96 | 0.97 | 0.97 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.16 | 3.16 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.